Athena Countouriotis
Directeur/Bestuurslid bij BIOMARIN PHARMACEUTICAL INC.
Vermogen: 23 058 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Asa Abeliovich | M | 60 |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Leal Therapeutics, Inc. develops novel therapeutics for patients with major disorders of the central nervous systems. | - |
| Edgar Cale | M | 60 | 5 jaar | |
| Jean-Jacques Bienaimé | M | 70 | 19 jaar | |
| Frederick Vogt | M | 50 | 8 jaar | |
| Alexander Hardy | M | 56 | 1 jaar | |
| Gini Deshpande | M | - |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | 16 jaar |
| Liam Ratcliffe | M | 60 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | 5 jaar |
| Maxine Gowen | M | 66 | 3 jaar | |
| Patrick P. Zarrinkar | M | - |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | - |
| Jean-Marc Bellemin | M | 51 | 4 jaar | |
| Laura Shawver | M | 66 |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| William Chou | M | 51 | 2 jaar | |
| Jeffrey Henderson | M | 59 | 9 jaar | |
| Merrill McPeak | M | 88 | 13 jaar | |
| Randy Meier | M | 65 | 18 jaar | |
| Sara Pellegrino | F | - | - | |
| Karen Smith | F | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Atul J. Butte | M | - |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | 16 jaar |
| Haig Aghajanian | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | 2 jaar |
| Dennis Joseph Slamon | M | 75 | 10 jaar | |
| Daniel K. Treiber | M | - |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | - |
| Elizabeth Anderson | F | 66 | 5 jaar | |
| Willard Dere | M | 70 | 8 jaar | |
| Sandipkumar S. Kapadia | M | 54 | 5 jaar | |
| James M. Wilson | M | - | 7 jaar | |
| Derrell Porter | M | 53 | 3 jaar | |
| Barbara Bodem | F | 56 | 1 jaar | |
| Philip Lo Scalzo | M | - | 17 jaar | |
| Brian Hodous | M | - |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | - |
| Nancy Whiting | M | 51 |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | 3 jaar |
| Stuart M. Henderson | M | - | 3 jaar | |
| David Pyott | M | 70 | 8 jaar | |
| Saqib Islam | M | 54 | 5 jaar | |
| Ryan Maynard | M | 54 | 9 jaar | |
| George Davis | M | 53 | 20 jaar | |
| Mark Alles | M | 64 | 2 jaar | |
| Wayne P. Rothbaum | M | 56 | 8 jaar | |
| Michael Weiser | M | 61 | 6 jaar | |
| Wendy Yarno | F | 69 | 1 jaar | |
| Elaine Heron | M | 76 | 22 jaar | |
| V. Lawlis | M | 72 | 17 jaar | |
| May Kin Ho | M | 71 | 3 jaar | |
| Brian Mueller | M | 50 | 22 jaar | |
| Kathleen Borthwick | F | 48 | 3 jaar | |
| Stuart Bunting | M | - | 16 jaar | |
| Mark Enyedy | M | 60 | 1 jaar | |
| Iain Dukes | M | 65 | 8 jaar | |
| Robert Hombach | M | 58 | 7 jaar | |
| Mohammad Hirmand | M | 54 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avenzo Therapeutics, Inc. is a biotechnology company that operates in the field of therapeutics. The company is based in San Diego, CA. The company was founded by Mohammad Hirmand and the CEO is Athena M. Countouriotis. | - |
| Jeff Ajer | M | 61 | 19 jaar | |
| Humaira Serajuddin | F | - | 2 jaar | |
| Erez Chimovits | M | 60 |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Erin Burkhart | F | 45 | 2 jaar | |
| Alex Fotopoulos | M | 55 | 5 jaar | |
| Eduardo Von Pervieux | M | - | 16 jaar | |
| Marni Kottle | F | - | - | |
| Michael Baran | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | 2 jaar |
| Andrew Levin | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Rajul Jain | F | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Tracy Winton | F | - | 4 jaar | |
| Jen Saunders | F | - | 3 jaar | |
| Ganesh Vedantham | M | - | 3 jaar | |
| Henry Fuchs | M | 66 | 15 jaar | |
| Andrea Campanile | F | - | - | |
| Igor Bilinsky | M | 51 | 3 jaar | |
| Rajul Jain | M | - |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| C. Guyer | M | 62 | 4 jaar | |
| Friedrich Finckenstein | M | 51 | 5 jaar | |
| Nandita Shangari | M | 43 |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | - |
| Traci McCarty | F | - | - | |
| Brinda Balakrishnan | M | 44 | 8 jaar | |
| Brad Glasscock | M | - | 12 jaar | |
| Dave Jacoby | M | - | 8 jaar | |
| Kevin Eggan | M | - | 4 jaar | |
| Ted Driscoll | M | 71 |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | - |
| Amy Wireman | F | - | 11 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Bill Welch | M | 62 | 2 jaar | |
| Amber Salzman | M | 62 | 2 jaar | |
| Timothy Morris | M | 61 | 3 jaar | |
| Stephen P. Squinto | M | 67 | 4 jaar | |
| Kathryn Falberg | F | 63 | 9 jaar | |
| Bruce Goldsmith | M | 58 | 2 jaar | |
| David Ramsay | M | 59 | 12 jaar | |
| Michael Swartzburg | M | 57 | 3 jaar | |
| Steven Schwartz | M | 62 | 11 jaar | |
| Harry Leonhardt | M | 67 | 5 jaar | |
| Maria Fardis | M | 56 | 5 jaar | |
| Samuel Barone | M | 51 | 3 jaar | |
| Michael E. Paolucci | M | 64 | 5 jaar | |
| Jean Bizzari | M | 69 | 9 jaar | |
| Patrick Heron | M | 53 | 3 jaar | |
| Jim Mazzola | M | - | 3 jaar | |
| Thomas Woiwode | M | 52 | 5 jaar | |
| Robert Engler | M | 79 | 11 jaar | |
| Tadataka Yamada | M | 77 | 4 jaar | |
| John Stuart Patton | M | 77 | 25 jaar | |
| Eric Carter | M | 72 | 4 jaar | |
| Alan Fuhrman | M | 67 | 4 jaar | |
| Homa Yeganegi | F | - | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 99 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Athena Countouriotis
- Persoonlijk netwerk
